Annual Retained Earnings
$9.78 B
+$560.58 M+6.08%
December 1, 2024
Summary
- As of February 7, 2025, GSK annual retained earnings is $9.78 billion, with the most recent change of +$560.58 million (+6.08%) on December 1, 2024.
- During the last 3 years, GSK annual retained earnings has fallen by -$939.20 million (-8.76%).
- GSK annual retained earnings is now -28.26% below its all-time high of $13.64 billion, reached on December 31, 2006.
Performance
GSK Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
$10.96 B
+$100.15 M+0.92%
September 30, 2024
Summary
- As of February 7, 2025, GSK quarterly retained earnings is $10.96 billion, with the most recent change of +$100.15 million (+0.92%) on September 30, 2024.
- Over the past year, GSK quarterly retained earnings has increased by +$2.39 billion (+27.97%).
- GSK quarterly retained earnings is now -30.22% below its all-time high of $15.70 billion, reached on June 30, 2007.
Performance
GSK Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
GSK Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.1% | +28.0% |
| 3 y3 years | -8.8% | -13.4% |
| 5 y5 years | +64.7% | -13.4% |
GSK Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.8% | +85.3% | -13.4% | +278.5% |
| 5 y | 5-year | -8.8% | +85.3% | -13.4% | +278.5% |
| alltime | all time | -28.3% | +211.8% | -30.2% | +223.1% |
GSK Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $9.78 B(+6.1%) | - |
| Sep 2024 | - | $10.96 B(+0.9%) |
| Jun 2024 | - | $10.86 B(+8.4%) |
| Mar 2024 | - | $10.02 B(+8.6%) |
| Dec 2023 | $9.22 B(+74.7%) | $9.22 B(+7.7%) |
| Sep 2023 | - | $8.56 B(+5.8%) |
| Jun 2023 | - | $8.10 B(+15.6%) |
| Mar 2023 | - | $7.00 B(+32.6%) |
| Dec 2022 | $5.28 B(-50.8%) | $5.28 B(+82.4%) |
| Sep 2022 | - | $2.89 B(-75.7%) |
| Jun 2022 | - | $11.92 B(-5.9%) |
| Mar 2022 | - | $12.66 B(+18.1%) |
| Dec 2021 | $10.72 B(+16.5%) | $10.72 B(+2.6%) |
| Sep 2021 | - | $10.45 B(+2.3%) |
| Jun 2021 | - | $10.21 B(+10.9%) |
| Mar 2021 | - | $9.21 B(+0.0%) |
| Dec 2020 | $9.21 B(+55.0%) | $9.21 B(+1.4%) |
| Sep 2020 | - | $9.08 B(+11.3%) |
| Jun 2020 | - | $8.15 B(+3.7%) |
| Mar 2020 | - | $7.86 B(+32.3%) |
| Dec 2019 | $5.94 B(-272.3%) | $5.94 B(-8.2%) |
| Sep 2019 | - | $6.47 B(-282.1%) |
| Jun 2019 | - | -$3.55 B(+11.7%) |
| Mar 2019 | - | -$3.18 B(-7.7%) |
| Dec 2018 | -$3.45 B(-60.6%) | -$3.45 B(+27.1%) |
| Sep 2018 | - | -$2.71 B(-22.6%) |
| Jun 2018 | - | -$3.50 B(-60.6%) |
| Mar 2018 | - | -$8.90 B(+1.7%) |
| Dec 2017 | -$8.75 B(+32.1%) | -$8.75 B(+21.9%) |
| Sep 2017 | - | -$7.18 B(-5.7%) |
| Jun 2017 | - | -$7.62 B(+24.4%) |
| Mar 2017 | - | -$6.12 B(-7.6%) |
| Dec 2016 | -$6.62 B(+220.1%) | -$6.62 B(-22.0%) |
| Sep 2016 | - | -$8.49 B(+3.7%) |
| Jun 2016 | - | -$8.19 B(+54.0%) |
| Mar 2016 | - | -$5.32 B(+156.9%) |
| Dec 2015 | -$2.07 B(-35.9%) | -$2.07 B(+101.7%) |
| Sep 2015 | - | -$1.03 B(-217.3%) |
| Jun 2015 | - | $874.31 M(-46.7%) |
| Mar 2015 | - | $1.64 B(-150.8%) |
| Dec 2014 | -$3.23 B(-314.4%) | -$3.23 B(+67.0%) |
| Sep 2014 | - | -$1.93 B(+618.2%) |
| Jun 2014 | - | -$269.10 M(-133.8%) |
| Mar 2014 | - | $795.63 M(-47.2%) |
| Dec 2013 | $1.51 B(+45.1%) | $1.51 B(-821.9%) |
| Sep 2013 | - | -$208.54 M(-133.0%) |
| Jun 2013 | - | $631.52 M(-67.9%) |
| Mar 2013 | - | $1.97 B(+89.8%) |
| Dec 2012 | $1.04 B | $1.04 B(-40.1%) |
| Sep 2012 | - | $1.73 B(-45.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $3.18 B(-49.6%) |
| Mar 2012 | - | $6.31 B(+21.6%) |
| Dec 2011 | $5.19 B(-29.6%) | $5.19 B(+5.8%) |
| Sep 2011 | - | $4.91 B(-32.2%) |
| Jun 2011 | - | $7.24 B(-9.6%) |
| Mar 2011 | - | $8.01 B(+8.6%) |
| Dec 2010 | $7.38 B(-27.8%) | $7.38 B(-20.0%) |
| Sep 2010 | - | $9.22 B(+25.6%) |
| Jun 2010 | - | $7.34 B(-29.1%) |
| Mar 2010 | - | $10.36 B(+1.3%) |
| Dec 2009 | $10.22 B(+51.0%) | $10.22 B(+12.1%) |
| Sep 2009 | - | $9.12 B(+30.1%) |
| Jun 2009 | - | $7.01 B(+5.8%) |
| Mar 2009 | - | $6.63 B(-2.1%) |
| Dec 2008 | $6.77 B(-47.4%) | $6.77 B(-7.3%) |
| Sep 2008 | - | $7.30 B(-13.9%) |
| Jun 2008 | - | $8.48 B(-25.2%) |
| Mar 2008 | - | $11.34 B(-11.9%) |
| Dec 2007 | $12.87 B(-5.6%) | $12.87 B(-7.7%) |
| Sep 2007 | - | $13.94 B(-11.2%) |
| Jun 2007 | - | $15.70 B(+10.8%) |
| Mar 2007 | - | $14.17 B(+3.9%) |
| Dec 2006 | $13.64 B(+42.1%) | $13.64 B(+5.0%) |
| Sep 2006 | - | $12.99 B(+4.8%) |
| Jun 2006 | - | $12.40 B(+4.0%) |
| Mar 2006 | - | $11.92 B(+24.2%) |
| Dec 2005 | $9.59 B(+6.5%) | $9.59 B(-0.9%) |
| Sep 2005 | - | $9.68 B(+7.6%) |
| Jun 2005 | - | $9.00 B(+0.1%) |
| Mar 2005 | - | $8.99 B(-0.2%) |
| Dec 2004 | $9.01 B(+24.8%) | $9.01 B(+27.9%) |
| Sep 2004 | - | $7.05 B(-6.4%) |
| Jun 2004 | - | $7.53 B(+23.1%) |
| Mar 2004 | - | $6.11 B(-15.3%) |
| Dec 2003 | $7.22 B(+52.1%) | $7.22 B(-2.8%) |
| Sep 2003 | - | $7.43 B(+10.6%) |
| Jun 2003 | - | $6.72 B(+20.3%) |
| Mar 2003 | - | $5.58 B(+17.6%) |
| Dec 2002 | $4.75 B(-16.9%) | $4.75 B(+5.5%) |
| Sep 2002 | - | $4.50 B(-6.5%) |
| Jun 2002 | - | $4.81 B(-9.6%) |
| Mar 2002 | - | $5.32 B(-6.9%) |
| Dec 2001 | $5.72 B(-10.3%) | $5.72 B(-19.8%) |
| Sep 2001 | - | $7.13 B(+5.0%) |
| Jun 2001 | - | $6.79 B(+8.8%) |
| Mar 2001 | - | $6.24 B(-2.1%) |
| Dec 2000 | $6.38 B(-2.5%) | $6.38 B(+946.0%) |
| Jun 1999 | - | $609.50 M(-7.4%) |
| Jun 1998 | - | $658.43 M(-89.9%) |
| Jun 1995 | - | $6.54 B |
| Jun 1995 | $6.54 B | - |
FAQ
- What is GSK annual retained earnings?
- What is the all time high annual retained earnings for GSK?
- What is GSK annual retained earnings year-on-year change?
- What is GSK quarterly retained earnings?
- What is the all time high quarterly retained earnings for GSK?
- What is GSK quarterly retained earnings year-on-year change?
What is GSK annual retained earnings?
The current annual retained earnings of GSK is $9.78 B
What is the all time high annual retained earnings for GSK?
GSK all-time high annual retained earnings is $13.64 B
What is GSK annual retained earnings year-on-year change?
Over the past year, GSK annual retained earnings has changed by +$560.58 M (+6.08%)
What is GSK quarterly retained earnings?
The current quarterly retained earnings of GSK is $10.96 B
What is the all time high quarterly retained earnings for GSK?
GSK all-time high quarterly retained earnings is $15.70 B
What is GSK quarterly retained earnings year-on-year change?
Over the past year, GSK quarterly retained earnings has changed by +$2.39 B (+27.97%)